This approach ensured that all potential inhibitors of the PRL signaling cascade were identified, and that ‘hits’ recognized by the more sensitive, non-human lymphocytes also blocked PRL signaling in PRLR-expressing breast cancer cells. The gene discussed is PRLR; the disease is breast cancer.